Recording Transactions: Intangible Assets

Section A CodeCrafters Ltd is developing a new proprietary software platform. During the year, they incurred $50,000 in early-stage research costs and $120,000 in development costs after the project was deemed commercially viable, technically feasible, and fully funded. How should these costs be treated in the financial statements for the year?

Section A BioGenetics acquired a patent on 1 January 20X3 for $100,000. The patent has a legal life of 15 years, but BioGenetics expects the product it protects to be obsolete in 10 years. On 31 December 20X4, an impairment review determined the recoverable amount of the patent was $75,000. What is the carrying amount of the patent in the statement of financial position as at 31 December 20X4? (Enter the number only)

Section A BioGenetics PLC is developing a new synthetic enzyme. Which TWO of the following criteria MUST be met for the development costs to be capitalized as an intangible asset under IAS 38?

Section A Which of the following best describes the accounting treatment for internally generated goodwill?